Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

IMV Inc IMVIQ

Healthcare Biotechnology
IMV Inc. is a Canada-based company. The Company has no business operations.


GREY:IMVIQ - Post by User

IMV Inc
Bullboard Posts
User Avatar Image
(43)
•••
Comment by Breakthorough1on Nov 20, 2018 8:32am
96 Views
Post# 28998555

RE:RE:RE:DPX-Survivac as Monotherapy For Recurring Ovarian Cancer

RE:RE:RE:DPX-Survivac as Monotherapy For Recurring Ovarian CancerThey will disclose it in the presentation of the 14th. of December. No need to speculate now. The selection of patients in the combination with Pembro is also related to the marker, so the results in this essay should be fantastic.
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities